News
07-20-2011, 10:11 PM
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
More... (http://www.news-medical.net/news/20110721/Promising-results-from-phase-I-study-of-Genentechs-GDC-0941-for-advanced-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20110721/Promising-results-from-phase-I-study-of-Genentechs-GDC-0941-for-advanced-breast-cancer.aspx)